-
GOP Congressman Says 'FDA Ignored Marijuana's Risks' In Rescheduling Proposal, Argues Agency's Credibility 'Challenged By COVID'
Friday, February 2, 2024 - 10:30am | 897A Republican congressman Dr. Andy Harris is issuing a letter to the Drug Enforcement Agency (DEA) criticizing the Department of Health and Human Services' (HHS) recommendation to reclassify cannabis to Schedule III under the federal Controlled Substances Act (CSA), first reported Fox New Radio. ...
-
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
Tuesday, January 2, 2024 - 12:44pm | 734The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024. In a notice scheduled to be published in the Federal Register on Wednesday, the agency said it is raising the proposed amounts as a response to a...
-
FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects
Friday, November 3, 2023 - 9:24am | 873Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug...
-
Congress Gets Warning Letter: Be Aware The DEA Is Breaking The Law, Cannabis Company Says
Wednesday, July 26, 2023 - 1:04pm | 950Cannabis researcher MMJ International Holdings Corp (MMJ) continues to fight with the Drug Enforcement Administration (DEA) over a bulk manufacturing application that was submitted almost five years ago, and never processed. Megan Sheehan of Sheehan & Associates, representing MMJ,...
-
FDA Is Inaccurately Using Incomplete Safety Data On CBD To Refuse Regulation, Says Hemp Non-Profit
Wednesday, May 31, 2023 - 11:42am | 719The hemp industry’s national advocacy organization, the U.S. Hemp Roundtable is not pleased with the recent Food and Drug Administration's presentation of a potential CBD framework. The coalition's general counsel, Jonathan Miller, wrote to key congressional leaders...
-
FDA Presents Potential Framework For CBD, From Edibles To Delta-8, Reaffirms Congress Is In Charge
Tuesday, May 30, 2023 - 10:20am | 900The U.S. Food and Drug Administration has not given up on regulating CBD and hemp-derived products in a way that would be safe for consumers and producers. Last week, the administration held a virtual panel “A New Way Forward for Cannabidiol and Other Hemp Products” for ...
-
FDA Funds Cannabis Study; NIDA Confirms 5 Entities Seek $25M Contract To Supply Research Weed
Monday, April 3, 2023 - 11:26am | 719The FDA is renewing a contract with Waterloo University to conduct a marijuana study, reported Cannabis Wire. Since 2019, the FDA and the University have been conducting International Cannabis Policy Study (ICPS), which surveys thousands of people across the U.S. and Canada...
-
Biden Praises Oregon Gov For Cannabis Pardons, FDA Warns CBD Companies Again, Thailand Saga Continues
Wednesday, November 23, 2022 - 10:28am | 1272President Joe Biden praised Oregon Governor Kate Brown (D) for following his example and recommendation by pardoning all simple marijuana convictions at the state level. On Monday, Gov. Brown announced a pardon for prior offenses of simple cannabis possession impacting...
-
Cannabis Regulatory Update: FDA On CBD Reg Stalling, NY Issues 58 Cannabis Grow Licenses, LA's State Worker Protections
Friday, May 20, 2022 - 11:14am | 674FDA Chief Recognizes Slow Progress On CBD Regulations Dr. Robert M. Califf confirmed on Thursday at a congressional panel that the FDA has made little progress on the regulatory framework around CBD products over the years since Trump signed the Farm Bill in late 2018. ...